In neoplastic diseases, USP40 mutations are associated with clinicopathological features such as poor survival in patients diagnosed with clear cell renal cell carcinoma (ccRCC), and can be used as diagnostic, prognostic and therapeutic markers for ccRCC [10]. Here, USP40 is linked to nonpapillary renal cell carcinoma.